Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated:  12/31/1969
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Wellness Programs for Brain-Injured Individuals
Evaluation of Wellness Programs for Brain-Injured Individuals
Status: Enrolling
Updated:  12/31/1969
VA Northern California Health Care System, Mather, CA
mi
from
Sacramento, CA
Wellness Programs for Brain-Injured Individuals
Evaluation of Wellness Programs for Brain-Injured Individuals
Status: Enrolling
Updated: 12/31/1969
VA Northern California Health Care System, Mather, CA
mi
from
Sacramento, CA
Click here to add this to my saved trials
Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress
Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress in University Students: Protocol for an Open Feasibility Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress
Effectiveness and Acceptability of Internet-delivered Treatment for Depression, Anxiety and Stress in University Students: Protocol for an Open Feasibility Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Rogers, AR
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Rogers, AR
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cerritos, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Culver City, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Culver City, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Garden Grove, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
National City, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
National City, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Oakland, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Oakland, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Oceanside, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Orange, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Orange, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Pico Rivera, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Riverside, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
San Diego, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
San Marcos, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
San Marcos, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Santa Rosa, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Colorado Springs, CO
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Bradenton, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Jacksonville, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Lauderhill, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Miami, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
North Miami, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
North Miami, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Orlando, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Atlanta, GA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Chicago, IL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Hoffman Estates, IL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Lake Charles, LA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Berlin, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cherry Hill, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Marlton, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Toms River, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Brooklyn, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cedarhurst, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Rochester, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Staten Island, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cleveland, OH
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Dayton, OH
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Oklahoma City, OK
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Allentown, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Allentown, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Norristown, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Norristown, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Philadelphia, PA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Memphis, TN
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Austin, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Dallas, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Houston, TX
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Everett, WA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Everett, WA
Click here to add this to my saved trials
Tapering Off Antidepressants
A Comparison of Two Antidepressant Tapering Regimens
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Tapering Off Antidepressants
A Comparison of Two Antidepressant Tapering Regimens
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Tapering Off Antidepressants
A Comparison of Two Antidepressant Tapering Regimens
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Tapering Off Antidepressants
A Comparison of Two Antidepressant Tapering Regimens
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials